Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Otsuka Holdings Co ( (JP:4578) ) has shared an update.
Otsuka Holdings reported first-quarter 2026 revenue of ¥630.3 billion, up 8.2% year on year, with business profit essentially flat at ¥123.0 billion and operating profit up 1.5%. Profit attributable to owners rose 15.7% to ¥98.3 billion, boosting basic earnings per share to ¥186.31 and lifting the equity ratio to 73.8%, reflecting a solid balance sheet despite modest profit growth.
The company kept its full-year 2026 guidance unchanged, projecting 2.1% revenue growth to ¥2.52 trillion but expecting double-digit declines in business profit and earnings versus 2025. Otsuka also reaffirmed its dividend forecast at ¥140 per share for 2026 and has factored ongoing share buybacks into its earnings-per-share outlook, underscoring a continued focus on shareholder returns while signaling more challenging profit conditions ahead.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen12500.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd., listed on the Tokyo Stock Exchange, operates in the healthcare and related fields, reporting under IFRS and focusing on pharmaceuticals and consumer health products. The group targets global markets and maintains a strong equity base, with equity attributable to owners representing more than 70% of total assets as of March 31, 2026.
Average Trading Volume: 1,274,300
Technical Sentiment Signal: Buy
Current Market Cap: Yen5702.9B
See more insights into 4578 stock on TipRanks’ Stock Analysis page.